The U.S. Food and Drug Administration granted accelerated approval to Bavencio (avelumab) for the Treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of Skin Cancer. “While […]